Neurotoxicities can be monitored long term with personalized questions, according to Mary Steinbach, DNP, APRN.

Notably, these data demonstrate that a nurse-led clinic could facilitate a system for patients to report their own symptom ...

The NCCN has added zongertinib to its guidelines for the care of patients with HER2 (ERBB2)-mutated non–small cell lung cancer.

BC, AOCNP, explained that adverse effects are common among the available antibody-drug conjugates in breast cancer.

Oncology nurses play a key role in monitoring, managing, and personalizing CDK4/6 inhibitor treatment to minimize toxicities ...

Barriers to CAR T-cell therapy exist for patients with multiple myeloma, even in urban areas, said Mary Steinbach, DNP, APRN, ...

A breast cancer survivorship expert shares her top advice for counseling patients on endocrine therapy at the 5-year mark.

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient ...

A care model led by advanced practice nurses was feasible in providing supportive care and linking providers through ...

Subcutaneous daratumumab offers shorter clinic visits and high tolerability for patients with multiple myeloma, says ...

Panelists discuss how evolving clinical advances and biomarker-driven therapies have transformed treatment practices and ...

Experts outline AE risks—including ICANS, CRS, HLH—as T-cell engager use expands, highlighting the crucial role of nurses and ...